ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
ALX ONCOLOGY HOLDINGS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.14+0.08 (+7.55%)
Close on Oct 19, 2026
- Market cap
- $154.63M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Alx Oncology has not reported a dividend
No dividend per share appears in Alx Oncology's annual filings since fiscal 2017.